The acquisition embeds physician-led virtual care into Quantum Health’s solutions, expanding immediate access to care, strengthening quality steerage and lowering costs.

Quantum Health, the leading healthcare navigation company, announced it has acquired CirrusMD, a premier on-demand virtual care company. The acquisition brings together navigation and physician-led virtual care to drive more immediate care integration and stronger outcomes for members across their healthcare journey.

This acquisition builds on Quantum Health’s recent momentum expanding clinically-validated provider steerage through Embold Health and launching its expanded solution suite built on a new agentic AI platform further strengthening the company’s ability to act earlier, guide members more effectively and deliver measurable savings.

Strengthening Real-Time Intercept with Physician-Led Care

Quantum Health’s unique Real-Time Intercept® model identifies critical healthcare moments as they happen, enabling earlier engagement with members and providers than traditional navigation programs and health plans. This acquisition strengthens that model by adding an embedded physician-led clinical team that can engage members earlier in their healthcare journey, often at their first moment of need, before care and costs escalate.

With our new virtual care capabilities, members can connect with a doctor in under 60 seconds through chat-first care available 24/7/365. Its physicians provide comprehensive virtual primary care and urgent care services. This includes annual wellness visits, weight management, women’s health, behavioral health support, lab orders, preventive screenings such as mammograms and colonoscopies, and more. Virtual care is typically lower cost to deliver than in-person care, making it a practical and scalable way to provide immediate clinical support while helping employers better manage healthcare spend.

Also Read: AxisCare Unveils AI Suite for Smarter Home Care 

Building on its quality foundation with Embold Health, which delivers clinically-grounded and personalized provider quality recommendations to members, Quantum Health is now further embedding direct physician care into navigation. This integration enables earlier comprehensive care and physician-driven referrals and proactive outreach, helping members avoid unnecessary emergency room visits, reduce delays and access the most appropriate, high-quality care from the start. The result is a more complete model delivering the right care, at the right time, at the right cost.

“Healthcare needs to work earlier, faster and cost less,” said Dayne Williams, Chief Executive Officer of Quantum Health. “By bringing CirrusMD’s physician-led virtual care directly into our navigation model, we are fundamentally strengthening Real-Time Intercept by engaging members sooner, improving outcomes and delivering meaningful healthcare cost containment for the employers and members we serve.”

Accelerating Innovation Through Agentic AI

The integration of CirrusMD will be powered by Quantum Health’s expanded solution suite built on its new agentic AI platform. Building a best-in-class human centered model, Quantum Health’s agentic AI proactively identifies care opportunities, surfaces next best actions and supports members, Care Coordinators, and now physicians with real-time insights that drive earlier and more effective engagement.

By weaving agentic AI throughout the combined navigation and virtual care platform, Quantum Health enhances its ability to deliver smarter, embedded steerage, ensuring members receive the right support with greater precision, clinical guidance, and personalization.

Combined Scale and Impact

Both organizations share a strong sense of purpose: helping members get the best care the moment they need it. By combining the two companies, they are closing the gaps in care, guiding members throughout their experience and ensuring timely outreach, engagement and follow-up.

“Our virtual care platform was built to remove barriers to care by giving people immediate and affordable access to trusted physicians,” said Jamie Hall, Chief Executive Officer of CirrusMD. “By joining Quantum Health, we can extend that impact even further by integrating real-time physician care directly into the navigation experience and helping millions of members move seamlessly from question to action.”

This move further cements Quantum Health’s leadership position in healthcare navigation by addressing a critical need: easy, always-on access to physician-led virtual care integrated directly into the navigation experience. Ultimately, this evolution positions Quantum Health as a more clinically enabled partner that acts earlier, guides members more effectively and delivers measurable improvements in health outcomes at scale.

The combined company will include over 2,300 team members known internally as Healthcare Warriors^® and serving more than 20 million members across private and public sector organizations throughout the United States.

Together, Quantum Health and CirrusMD are redefining how navigation and care come together, meeting members where they are and guiding them forward with clarity, confidence and clinical expertise.

The post Quantum Health Acquires CirrusMD for Physician-Led Virtual Care appeared first on ITDigest.

Also Read: Innate Pharma gets FDA nod for Phase 3 TELLOMAK trial 

Rather than replacing human clinicians, the AI component is designed to supplement traditional care “using AI to improve responsiveness to patients, enhance information gathering and utilization, and improve overall care delivery while maintaining a live physician model.” John D’Angelo, CEO of Northwell, remarked, “This new joint venture represents a significant step forward in making quality healthcare more accessible to our patients.” And according to Ran Shaul, Co-founder & CPO at K Health, “We are redefining primary care and defining a new patient-centric standard of care. The K Health technology will be available to millions of patients … The partnership with Northwell represents a tremendous opportunity to change primary care for the better of patients and providers.” This initiative joins other leading systems such as Cedars-Sinai, Hackensack Meridian, Hartford HealthCare, Mass General Brigham, and Mayo Clinic in partnering with K Health to scale AI-driven primary care delivery.

Read More: Northwell Health and K Health Launch Virtual Primary Care Platform Powered by Clinical AI

The post Northwell Health and K Health Launch 24/7 AI-Driven Virtual Primary Care appeared first on ITDigest.

Built directly into AxisCare’s industry-leading home care management platform, AxisCare Intelligence delivers real-time insights, automation, and decision support to help agencies reduce administrative burden, enhance caregiver performance and retention, and improve client outcomes.

“At AxisCare, we are committed to developing technology that helps agencies operate more efficiently and deliver care more meaningfully,” said John Atkinson, CTO & COO of AxisCare. “AxisCare Intelligence was built to make home care operations easier, scalable, and more human by turning data into real-time insights that drive smarter decisions, stronger performance, and better outcomes.”

Also Read: Arya Health Raises $18.2M to Advance AI in Post-Acute Care 

Available AI-Powered Features Include:

• Axi, AI Chat Assistant : An intelligent chat assistant that allows users to quickly access information, view insights, and complete tasks through interaction. Built with role-based access controls, Axi maintains confidentiality while supporting agency-wide efficiency.
• Automated Open Visit Recommendations : A scheduling tool that automatically identifies and recommends caregiver matches for open visits based on availability, skills, and client compatibility, improving scheduling accuracy and speed.
• Care Analytics : A data analysis feature that reviews care and ADL notes to detect trends, categorize client concerns, and prioritize follow-up actions, providing agencies with clear visibility into client well-being.

“AxisCare Intelligence reflects our vision for the future of home care,” said Todd Allen, CEO of AxisCare. “By simplifying operations and providing real-time insights, these tools help agencies work more efficiently and give caregivers the time and information they need to provide the highest-quality care while maintaining the human touch that defines this industry.”

AxisCare Intelligence is now available to all AxisCare customers as part of the company’s ongoing commitment to innovation and user-centered design.

Source: PRNewswire

The post AxisCare Unveils AI Suite for Smarter Home Care appeared first on ITDigest.

Prochant PulseIQ boosts Prochant’s end-to-end RCM services with intelligent automation, predictive analytics and guided workflows that are all designed to help Prochant’s teams work smarter, faster and with greater accuracy. It gives teams the data and insights they need to make better decisions, resolve issues proactively and deliver exceptional financial results for clients.

AI Built in Across the Revenue Cycle

Delivered through Prochant’s tech-enabled services, Prochant PulseIQ brings automation and intelligence to every stage of the revenue cycle:

• Intake: Accelerates the intake and onboarding process by automatically extracting and validating data from clinical and insurance documents while integrating seamlessly with electronic health records (EHRs). This automation speeds up referral processing, reduces the risk of manual errors that lead to denials and improves the accuracy of insurance verification and order setup, ensuring that patients are onboarded quickly and correctly.
• Billing: Advanced logic to review 100% of claims automatically, identifying potential errors or missing information before submission. This functionality improves clean claim rates, reduces denials and eliminates the need for time-consuming manual reviews, enabling faster reimbursements, and allowing billing teams to focus on more complex, high-value tasks that drive revenue growth.
• Collection: Empowers our teams to optimize collections by prioritizing denials based on payment probability and guides workflows based on denial type and payer. This data-driven approach helps teams concentrate on the claims most likely to result in recovery, improving denial overturn rates and shortening accounts receivable (A/R) cycles.

Also Read: Arya Health Raises $18.2M to Advance AI in Post-Acute Care 

Early adopters have already achieved significant performance gains. Prochant teams working within Prochant PulseIQ’s AI-enhanced workflows and analytics have helped clients achieve up to a 56% improvement in denial rates, a 25% improvement in days sales outstanding (DSO) and a 17% improvement in payment rates over a six-month period.

“Prochant PulseIQ is an extension of our people – not a replacement for them,” said Joey Graham, CEO of Prochant. “We don’t sell software; we deliver outcomes. By embedding AI directly into our RCM services, we give our teams, and our clients, the intelligence to resolve issues proactively and perform at a higher level.”

Source: PRNewswire

The post Prochant Unveils PulseIQ™ AI Suite to Boost Home Care Revenue appeared first on ITDigest.

 Arya Health (Arya), an AI company helping home health and post-acute care providers automate scheduling, compliance, and other administrative operations, announced its $18.2 million Series A funding. The round was led by ACME Capital, with participation from Ridge Ventures, Twelve Below, executives from OpenAI, and leading post-acute care providers, bringing Arya’s total funding to $25 million.

Post-acute care providers, including home healthcare agencies, hospice providers, and long-term care facilities, are facing unprecedented strain. Rapid regulatory changes, caregiver shortages, and escalating wage pressures are pushing an already margin-constrained industry to the brink. Meanwhile, heavy private equity investment and consolidation call for a renewed focus on operational excellence and thinking beyond the traditional “people-heavy” approach to post-acute care administration.

Arya is building a new AI-native “system of action” that sits alongside the Electronic Medical Record (EMR) to automate the heavy administrative load that burdens front office teams, slows growth, and diverts resources from patient care and caregiver support.

“Post-acute care organizations spend roughly 25 cents of every dollar on non-clinical tasks,” said Kunal Sarda, CEO and co-founder of Arya Health. “That’s time and money that should be going toward caregivers and patients, not process. Arya is flipping that equation by using AI to take on the operational burden so providers can focus on delivering care, not moving patients, caregivers, and data around in their EMR. Our mandate is to make post-acute care administration more scalable, human, and cost-effective at the same time.”

Also Read: DUOS Gets $130M Growth Investment Led by FTV Capital

Arya’s AI-powered digital agents automate key post-acute care workflows, including caregiver scheduling, compliance tracking, and hiring pipeline management. Embedded in daily operations, these agents continuously learn and adapt to increase workforce efficiency. Recent innovations include the Onboarding Agent, which reduces time-to-first-staffing by 50% with 70% less administrative effort; the Talent Acquisition Agent, which autonomously recruits and schedules caregivers with 60% less human effort; and the Compliance Agent, which eliminates manual license tracking and deploys in just one week. The company is also preparing to launch an Intake Agent in Q4, designed to accelerate patient start of care and reduce critical back-office bottlenecks.

The new funding will enable Arya to expand its product suite across additional administrative functions and scale hiring to keep pace with market demand. Arya has grown revenue more than 6x in 2025 and is on track for 10x year-over-year growth by year-end.

As part of this next phase, Arya has appointed Melinda Phillips, former CEO of Thrive Skilled Pediatric Care (acquired by Aveanna), to lead its Care@Home Center of Excellence, where she will help scale AI adoption across the home care sector. A veteran operator of one of the nation’s largest post-acute providers, she brings deep industry experience to Arya’s technology-driven team, strengthening the company’s blend of insider expertise and outsider innovation.

“Arya represents exactly the kind of innovation post-acute care needs right now,” said Aike Ho, Partner at ACME Capital. “They’re pairing deep operational expertise with cutting-edge AI to unlock entirely new economics for providers, without sacrificing the humanity at the heart of care.”

Source: PRNewswire

The post Arya Health Raises $18.2M to Advance AI in Post-Acute Care appeared first on ITDigest.

In conjunction with the investment, DUOS promoted Jenn Kerfoot to President of Market Operations to continue advancing commercial success and positioning DUOS as the operating layer to drive both member engagement and measurable plan performance leveraging AI.

“I started DUOS with the belief that health plans could do more to support older adults not just with resources, but also with meaningful follow-through,” said Karl Ulfers, CEO and Co-founder of DUOS. “That belief has only deepened as we’ve helped more members navigate complex systems and delivered outcomes for plans under pressure. Our AI ensures the right action happens at the right time. FTV shares our vision for what’s possible, and their partnership and track record in the healthcare sector optimally positions us to continue growing with purpose. Jenn’s promotion also reflects the kind of leadership this next chapter deserves as we continue scaling our impact and evolving how we serve both members and plans.”

Medicare Advantage enrollment has grown significantly, now covering more than half of all beneficiaries, as health plans face rising pressure to improve outcomes, manage costs and reduce churn. At the same time, members must navigate increasingly complex benefits, digital barriers and unmet social and clinical needs that directly affect plan performance. These challenges are pervasive, yet most engagement solutions stop at outreach, failing to close the loop between benefit design and member action. Plans are left with fragmented tools, incomplete data and lagging indicators that hinder Star Ratings, risk adjustment and retention resulting in avoidable revenue loss and increased operational costs.

Also Read: AmplifyMD Secures $20M Series B to Transform Health Care

DUOS addresses this challenge head-on with an AI-powered infrastructure that ensures its members not only engage but follow through. Founded in 2020, DUOS’ member experience and performance platform guides members through the benefits and services they already have, but too often go unused. From helping members retain coverage through Medicaid redetermination and enroll in government programs like LIS, to coordinating care through Annual Wellness Visit scheduling and mail-order pharmacy enrollment, DUOS ensures members complete high-value actions that directly impact plan revenue and retention. Embedded throughout the platform, DUOS’ AI learns from member behavior and intent, identifies what to do next and deploys intelligent digital and human support at the moment it’s needed.

“Most health tech promises to improve engagement, but DUOS actually proves it, with real completion rates and measurable impact,” said Alex Mason, Partner at FTV Capital. “At FTV, we’ve spent decades investing in healthcare innovation, and DUOS stands out for leveraging AI to build the critical infrastructure health plans need to operate efficiently and improve member outcomes at scale. We’re thrilled to support the company in building on its impressive momentum and driving the platform’s continued expansion.”

“DUOS was built to solve what we see as healthcare’s final-mile problem,” said Jenn Kerfoot, President of Market Operations at DUOS. “We’re not just solving for today’s engagement challenges. We’re building the infrastructure health plans need, not only for the members we serve now, but also for the version of this system we’ll inherit ourselves one day.”

Source: Businesswire

The post DUOS Gets $130M Growth Investment Led by FTV Capital appeared first on ITDigest.

The raise, led by Forerunner Ventures with participation from F-Prime, Greylock, Tau Ventures, and strategic partner Memorial Hermann Health System, will accelerate AmplifyMD’s AI-driven platform capabilities and advance sustainable clinical coverage for hospitals under pressure to do more with less.

Since its launch in 2019, AmplifyMD has established itself as the clear leader in delivering seamlessly integrated multispecialty virtual care across any clinical setting, through its EHR-integrated, AI-enabled platform and integrated clinical network covering 15+ medical specialties.

Also Read: PHIL Unveils Direct-to-Patient 2.0 to Transform Pharma

“AmplifyMD isn’t just enabling telehealth it’s reimagining how health systems leverage their clinical resources,” said Eurie Kim, Managing Partner at Forerunner. “Their automation-first approach to virtual care workflows delivers immediate efficiency gains and lays a  foundation for sustainable models hospitals can rely on for years to come.”

AmplifyMD transforms fragmented data and limited provider capacity into coordinated, systemwide coverage. The platform brings essential patient information to the point of care and uses intelligent distribution to extend providers across multiple sites and departments. The impact: faster consults, higher productivity, reduced patient transfers, improved revenue cycle outcomes, and smarter use of resources helping health systems deliver consistent, high-quality care whenever and wherever it is needed.

“At Memorial Hermann, we look for innovation that addresses challenges in a fundamentally different way,” said Feby Abraham, Executive Vice President & Chief Strategy Officer. “AmplifyMD stands out because it combines AI-enabled workflows with on-demand specialty coverage, creating a scalable model that expands access, improves quality, and lowers costs.”

AmplifyMD’s platform is producing meaningful outcomes at scale, including:

• 52% reduction in TeleStroke operational costs
• 2x increase in TeleHospitalist cross-cover consults per shift
• Outpatient specialty care wait times cut from months to days

“Over the past few years, we’ve seen just how transformational our solutions can be,” said Meena Mallipeddi, CEO and Co-founder of AmplifyMD. “Health systems using our platform, and when needed, our physician network across 15+ fields, are proving it’s possible to deliver care that is faster and more sustainable, with less strain on existing resources.”

With this new investment, AmplifyMD plans to scale to meet a broader set of needs for its health system partners, enabling hospitals and care organizations to turn virtual coverage into a sustainable advantage. This new capital will also accelerate AmplifyMD’s development of AI and clinical workflow capabilities, enable deeper strategic partnerships across its health system footprint, and fuel long-term care delivery transformation across the country.

Source: PRNewswire

The post AmplifyMD Secures $20M Series B to Transform Health Care appeared first on ITDigest.

PHIL, a leader in patient access solutions for the life sciences industry, announced the launch of PHIL Direct, its Direct-to-Patient (DTP) 2.0 platform, designed to help pharmaceutical brands meet evolving patient expectations while navigating affordability, compliance, and policy pressures.

Direct-to-patient access has evolved from a tactical experiment to a strategic, executive-level priority, as policy shifts, competitive pressures, and consumer demand converge. The consumerization of healthcare is real patients now demand the same frictionless, digital experiences they get from modern e-commerce. However, cost remains a major barrier to access. The challenge is especially acute in high-demand categories like GLP-1 medications.

Despite widespread interest, direct-to-consumer GLP-1 offerings are often priced at $499 per month out of reach for most. While insured patients might pay as little as $25, studies show 47% of consumers cite cost as the primary barrier, and 36% of former users discontinued treatment due to affordability. Yet the reality of the drug channel, which is characterized by prior authorization hurdles, and complex benefit designs, continues to hinder access, even when coverage exists.

PHIL’s DTP 2.0 platform is designed to close this gap by enabling a coverage-first model, with cash-pay as a bridge or fallback pairing affordability with long-term adherence support. The platform integrates telemedicine, digital hub, prescription fulfillment, real-time patient navigation, and full-spectrum insights into a single digital front door, ensuring a compliant, consumer-grade experience.

Also Read: Neuroglee & Mayo Clinic Partner on At-Home Dementia Care Solutions 

“Direct-to-Patient has shifted from experiment to imperative for pharma,” said Deepak Thomas, Founder and CEO, PHIL. “GLP-1s have been a case study in both the demand for these therapies and the barriers that prevent patients from staying on them. Backed by over five years of success enabling DTP for leading brands, we’re proud to launch PHIL Direct our DTP 2.0 platform that empowers patients to start and stay on therapy affordably, while giving pharma the guardrails required for scalable, compliant growth.”

Sari Kaganoff, Former Chief Commercial Officer, Rock Health, added, “Pharma has experimented with DTP for years now, but it’s been in small pockets. Now with policy shifts demanding DTP options, leading pharma companies going big, and changing consumer expectations, the industry is forced to take action. PHIL’s DTP 2.0 solution provides a way for companies to quickly launch a DTP offering that maximizes access and affordability.”

Michelle Keefe, Former Chief Executive Officer, Syneos Health, shared her perspective, “Pharma brands today face a critical challenge – the traditional path to access is filled with high barriers and friction points for patients. Direct-to-patient programs are shifting the paradigm, creating a seamless digital experience for patients that empowers brands to build a more resilient and profitable commercial strategy.”

Source: Businesswire

The post PHIL Unveils Direct-to-Patient 2.0 to Transform Pharma appeared first on ITDigest.

UH operates one of the largest healthcare networks in Northern Ohio, combining advanced clinical innovation with research and academic excellence. As the RPM program scales across the UH Primary Care Institute, it will extend to nearly 100 practice sites and empower more than 400 providers to proactively manage patients with chronic conditions.

“At University Hospitals, we are committed to pushing the boundaries of what’s possible in care delivery,” said Dr. Anthony Muni, Chief Medical Officer, Utilization Management & Clinical Documentation Integrity. “Collaborating with HealthSnap enables us to better support patients with uncontrolled hypertension between visits, helping them stay connected, adherent, and on track toward healthier outcomes.”

Also Read: Neuroglee & Mayo Clinic Partner on At-Home Dementia Care Solutions

The RPM program leverages continuous biometric and symptom monitoring to improve blood pressure control, reduce hospital readmissions, and enable earlier interventions. By integrating HealthSnap’s platform directly into UH’s existing workflows and electronic health record (EHR) systems, clinicians can deliver proactive, data-driven care without disruption to their daily practice.

“University Hospitals is leading the way in redefining chronic care for the modern era,” said Samson Magid, CEO of HealthSnap. “We are proud to support their bold vision with scalable RPM solutions that deliver meaningful outcomes without adding to provider burden.”

Through this strategic partnership, UH and HealthSnap are setting a new benchmark for chronic disease management, aiming to improve patient outcomes while reducing unnecessary hospital visits and healthcare costs.

The post University Hospitals Rolls Out HealthSnap RPM for Hypertension appeared first on ITDigest.

Patients with cognitive impairment and dementia can be enrolled in Neuroglee’s program for longitudinal virtual cognitive and dementia care delivered by a specialized team of advanced practice nurses, licensed social workers, pharmacists, and care navigators, with supervision from neurologists and geriatric psychiatrists, all delivering high-touch, wraparound support 24/7.

Neuroglee’s whole-person-focused solutions emphasize care partner enablement, in-home care continuity, and hospital utilization avoidance. Throughout the dementia care journey, care teams improve patient outcomes and experience while controlling costs through proactive symptom management, efficient testing and diagnosis, and remote monitoring coupled with comprehensive care partner enablement and support.

“Neuroglee’s clinically proven, technology-enabled care model builds upon Mayo Clinic’s expertise to provide long-term, individualized care that supports both patients and care partners at home,” said Neuroglee Founder and CEO Aniket Singh Rajput. “This expanded collaboration is a milestone in our mission to lower the total cost of dementia care while improving outcomes, access, and experience for families navigating cognitive decline. As value-based care payment models continue to proliferate across the industry, our partnership with Mayo Clinic demonstrates to risk-bearing entities that Neuroglee is ready to scale our solution to help providers and patients achieve their goals.”

Also Read: Prevounce Health Adds AI Insights to Remote Care Platform

The rollout aligns with Neuroglee’s selection for the Center for Medicare & Medicaid Innovation’s GUIDE (Guiding an Improved Dementia Experience) Model, a first-of-its-kind payer initiative to bring comprehensive value-based dementia care to Medicare beneficiaries. Neuroglee will be enrolling GUIDE-eligible patients across Mayo Clinic locations and other partner sites at no cost to the patient or family.

The average annual per-member cost to Medicare for patients with dementia is $22,000, almost three times the cost of members who do not have Alzheimer’s or another dementia. However, with Neuroglee’s comprehensive, proactive dementia care model, payers and risk-bearing entities have the ability to save over $6,300 per member per year through early detection and comprehensive longitudinal care. That is because Neuroglee’s care model is designed to address the known drivers of high-cost utilization and dynamically adapts based on the patient’s diagnosis and cognitive stage, focusing on patient-centric support in the early stages and transitioning to care partner-centered enablement and support as dementia progresses.

By combining world-class clinical expertise with personalized technology and a scalable care model, Neuroglee is delivering new hope to patients, care partners and risk-bearing healthcare organizations alike. As this growth momentum accelerates, supported by strategic partnerships, national programs such as GUIDE, and expanding payer engagement, Neuroglee remains committed to reshaping cognitive care delivery from diagnosis through end of life.

Source: PRNewswire

The post Neuroglee & Mayo Clinic Partner on At-Home Dementia Care Solutions appeared first on ITDigest.